Form D · Biotechnology
Intelomed, Inc.
Pittsburgh, PA · CIK 0001482781
Offering snapshot reported Jan 9, 2017 · SEC filing
- Reported sold
- $502K Offering amount: $1.5M
- Investors reported
- 10 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Dec 23, 2016 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jan 9, 2017 | Initial | $502,429 | No comparison | 10 | SEC filing |
| Jan 29, 2016 | Amendment | $1,855,410 | $0vs Jan 27, 2016 | 8 | SEC filing |
| Jan 27, 2016 | Initial | $1,855,410 | No comparison | 8 | SEC filing |
| Jul 23, 2014 | Initial | $3,846,926 | No comparison | 29 | SEC filing |
| Sep 10, 2013 | Initial | $2,404,582 | No comparison | 22 | SEC filing |
| Dec 5, 2012 | Initial | Yet to sell | No comparison | 0 | SEC filing |
| May 24, 2011 | Initial | $2,611,000 | No comparison | 15 | SEC filing |
| Feb 1, 2010 | Initial | $200,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Debt
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-277998
The intended total offering amount is up to $1,500,000 with multiple closing dates scheduled to occur.
Source: Form D, filed Jan 9, 2017. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Frank J Amoruso | Director, Executive |
| Jan Berkow | Director, Executive |
| Mary Del Brady | Director |
| Michael Dignazio | Executive |
| R. Stephen Doyle | Director |
| Ned Laubacher | Director |
| William P. Malloy | Director |
| John Moran | Director |
| Mark Rossi | Director |
| Jill F. Schiaparelli | Director, Executive |
| James Sweeney | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
Pine Corporate Center 3 6041 Wallace Road Ext, Suite 110
Pittsburgh, PA, 15090
Pittsburgh, PA, 15090